Supreme Pharmaceuticals Inc.
Supreme Pharmaceuticals Inc. ("Supreme") (CSE:SL; OTCBB:SPRWF) is a publicly traded marijuana company based in Toronto, Canada. Supreme’s wholly owned subsidiary, 7ACRES/AMMcan, was issued a Canadian federal license to cultivate medical marijuana pursuant to the Marihuana for Medical Purposes Regulations on March 11, 2016 (now the ACMPR). Supreme is one of the newest marijuana Licensed Producers (LP) in Canada’s marijuana market, and is well positioned with its high capacity innovative hybrid greenhouse and B2B focused business model.
Supreme Pharmaceuticals Inc. (SL)
June 1, 2017
The common shares of Supreme Pharmaceuticals Inc. will be delisted at the market close, June 5, 2017.
Supreme Pharmaceuticals will continue to trade on the TSX Venture Exchange.
Date: Market close, June 5, 2017
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com